Salute e Benessere
Genomics Personalized Health Market to reach US$ 33 Billion by 2034, Driven by Advances in Next-Generation Sequencing - Transparency Market Research, Inc.
The genomics personalized health market is rapidly evolving, fueled by cutting-edge technological advancements and an increasing focus on individualized healthcare. One of the key drivers of this market is the advent of next-generation sequencing (NGS) technologies, which have drastically reduced the cost and time required for sequencing the human genome.
This has made genomic data more accessible, enabling healthcare providers to tailor treatments to the genetic profiles of individual patients. The market is also benefitting from advancements in bioinformatics and computational biology. These fields are essential for managing and interpreting the vast amounts of data generated by genomic studies.
Artificial intelligence (AI) and machine learning (ML) are being increasingly integrated into genomics, enhancing the ability to identify genetic markers for diseases, predict patient responses to treatments, and discover new therapeutic targets. In terms of market trends, there is a growing emphasis on preventive healthcare and early disease detection.
Personalized health genomics plays a crucial role in these areas by identifying individuals at high risk for certain conditions, allowing for early interventions and lifestyle modifications. The rise of direct-to-consumer (DTC) genetic testing is another notable trend.
Key players operating in the genomics personalized health market landscape are offering robust precision medicine genomics services and programs that leverage predictive analytics to provide targeted treatment regimens.
These services help prevent and treat diseases at their earliest stages when they are most treatable. Some prominent genomics personalized health providers are:
Companies like 23andMe and AncestryDNA have popularized personal genomics, enabling consumers to access their genetic information and gain insights into their ancestry, traits, and health predispositions. Strategic partnerships and collaborations are shaping the market landscape.
Pharmaceutical companies are partnering with genomic research firms to develop targeted therapies, while technology companies are collaborating with healthcare providers to integrate genomic data into electronic health records (EHRs). These collaborations are fostering innovation and expanding the applications of genomic technologies.
, a global registered at Wilmington, Delaware , United States , provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
:
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
+1-518-618-1030
: 866-552-3453
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/genomics-personalized-health-market-to-reach-us-33-billion-by-2034-driven-by-advances-in-next-generation-sequencing---transparency-market-research-inc-302207598.html